In patients with CD4 counts <50 cells/mm3 and those with CD4 counts ≥50 cells/mm3 who have severe clinical disease, ART should be initiated within 2 weeks of starting TB treatment as shown in Table 2. This evidence concerns the gene CD4 and tuberculosis.